A
Anthony E. Wiskin
Researcher at Bristol Royal Hospital for Children
Publications - 8
Citations - 618
Anthony E. Wiskin is an academic researcher from Bristol Royal Hospital for Children. The author has contributed to research in topics: Inflammatory bowel disease & Guideline. The author has an hindex of 2, co-authored 8 publications receiving 364 citations.
Papers
More filters
Journal ArticleDOI
ESPEN guideline: Clinical nutrition in inflammatory bowel disease
Alastair Forbes,Johanna C. Escher,Xavier Hébuterne,Stanislaw Klek,Zeljko Krznaric,Stéphane M. Schneider,Raanan Shamir,Kalina Stardelova,Nicolette J. Wierdsma,Anthony E. Wiskin,Stephan C. Bischoff +10 more
TL;DR: The recommended perioperative management of patients with IBD undergoing surgery accords with general ESPEN guidance for patients having abdominal surgery, and primary therapy using nutrition to treat IBD is moderately well supported in Crohn's disease.
Journal ArticleDOI
ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease
Stephan C. Bischoff,Johanna C. Escher,Xavier Hébuterne,Stanislaw Klek,Zeljko Krznaric,Stéphane M. Schneider,Raanan Shamir,Kalina Stardelova,Nicolette J. Wierdsma,Anthony E. Wiskin,Alastair Forbes +10 more
TL;DR: The present guideline is the first of a new series of "practical guidelines" based on more detailed scientific guidelines produced by ESPEN, and includes flow charts that connect the individual recommendations to logical care pathways and allow rapid navigation through the guideline.
Journal ArticleDOI
Prevalence of home parenteral nutrition in children
TL;DR: In this paper, a national database was interrogated to define the prevalence of HPN in children in the UK and to explore outcomes for patients receiving HPN, finding that long-term HPN is safe and associated with good survival and low risk of the need for intestinal transplantation.
Journal ArticleDOI
Change in Incidence and Epidemiology of Inflammatory Bowel Disease in 2- to 9-Year-olds in Southwest England.
TL;DR: In this paper, a population-based retrospective cohort study of all <10-year-olds diagnosed with Inflammatory Bowel Disease (IBD) between 2004 and 2017 in Southwest England was performed.
Journal ArticleDOI
Corrigendum to 'ESPEN guideline: Clinical nutrition in inflammatory bowel disease' [Clinical Nutrition 36 (2) (2016) 321-347].
Alastair Forbes,Johanna C. Escher,Xavier Hébuterne,Stanislaw Klek,Zeljko Krznaric,Stéphane M. Schneider,Raanan Shamir,Kalina Stardelova,Nicolette J. Wierdsma,Anthony E. Wiskin,Stephan C. Bischoff +10 more
TL;DR: The recommendations 14A, 32A, 33A, and 33B, which recommend “VSL#3 ® ”, refer only to the product used in the cited literature and equivalent products independent from the present product labelings.